Independently tested/Batch-level documentation
BPC-157/TB-500 Blend illustrative clear glass vial with Lana Peptides label

Illustrative image. Catalogue strength: 10 mg / 10 mg; image label may differ.

BPC-157/TB-500 Blend

Research MaterialSample Results Published

A blended reference material containing BPC-157 and TB-500 (thymosin beta-4 fragment), supplied for in-vitro laboratory research.

Material
BPC-157/TB-500 Blend
Form
Lyophilized powder
Vial quantity
10 mg / 10 mg · 1 vial
Batch number
BLD-502
Testing status
Report published
Storage
Store lyophilized material at -20 °C, protected from light. Once reconstituted, refrigerate at 2–8 °C and handle under standard laboratory practice.
Provisional retail price · CAD$80.00
Price$80.00
1

Supplied for laboratory research use only. Not for human or veterinary use.

Verification

Latest Test Results

Batch: BLD-502

Identity
Reported components: BPC-157 and Thymosin β4 (HPLC-MS/MS).
Quantity
BPC-157: 12.14 mg; Thymosin β4: 11.85 mg; total net content: 23.99 mg (tested sample).
Purity
BPC-157: 99.71%; Thymosin β4: 99.70% chromatographic purity (tested sample).
Additional testing
No endotoxin or sterility results supplied.
Independent laboratory
Peptide Test Canada / Side-Chain Analytics Inc.
Testing date
November 5, 2026

Laboratory sample ID BLD-502; report COA-2026-SC-04742; verification reference PTC-87JHUVCY. Received October 29, 2026; analyzed and reported November 5, 2026. This record uses the laboratory sample ID, not a confirmed inventory lot number. The laboratory names the second component Thymosin β4. Results apply only to the sample as received, not other vials or any entire lot or batch. They do not establish safety, efficacy, regulatory compliance, or suitability for human or veterinary use. Laboratory permission to display the full report was confirmed by the owner.

Batch archive

Material Overview

BPC-157 / TB-500 is supplied as a blended peptide reference material. BPC-157 is a synthetic pentadecapeptide sequence derived from a gastric protein fragment; TB-500 refers to a synthetic peptide related to thymosin beta-4. The blend is prepared for laboratory research use and each batch is submitted for independent analytical testing.

Research Context

BPC-157 and thymosin beta-4 related peptides have been examined in preclinical literature in the context of cellular migration, angiogenesis signalling and tissue-model studies. Published work is largely preclinical and does not establish clinical efficacy.

Storage & Handling

Store lyophilized material at -20 °C, protected from light. Once reconstituted, refrigerate at 2–8 °C and handle under standard laboratory practice.

Molecular Information

Peptide sequence
BPC-157: GEPPPGKPADDAGLV
Molecular formula
BPC-157: C62H98N16O22
Molecular weight
BPC-157: 1419.53 g/mol
CAS number
137525-51-0 (BPC-157)
Synonyms
Body Protection Compound 157; Thymosin beta-4 fragment
Research classification
Peptide blend reference material

Common questions about BPC-157/TB-500 Blend

What purity is BPC-157/TB-500 Blend tested to?
Our specification is Reported per batch. Each lot's sample is sent to an independent third-party laboratory, and published reports apply only to the sample tested.
How should BPC-157/TB-500 Blend be stored?
Store lyophilized material at -20 °C, protected from light. Once reconstituted, refrigerate at 2–8 °C and handle under standard laboratory practice.
What strength and form is supplied?
10 mg / 10 mg per vial, supplied as lyophilized powder.
Where does BPC-157/TB-500 Blend ship from?
Orders are processed and dispatched within Canada. Shipping is $22 CAD on orders under $300 and free at $300 or more.
Is BPC-157/TB-500 Blend for human use?
No. It is sold strictly for laboratory research use only and is not for human or veterinary consumption.
BPC-157/TB-500 Blend
10 mg / 10 mg · $80.00 CAD
1